Cell Growth & Differentiation, Vol 7, Issue 10 1369-1381, Copyright © 1996 by American Association of Cancer Research

ARTICLES

A novel cis-acting element is involved in the promoter activity of the rat mdr1b gene

G Zhou, R Song and MT Kuo
Department of Molecular Pathology, University of Texas M. O. Anderson Cancer Center, Houston, 77030, USA.

Multidrug resistance (MDR) is often associated with overexpression of P-glycoprotein, which is encoded by the mdr gene family. Three mdr genes, i.e., mdr1a (mdr3), mdr1b (mdr1), and mdr2 are present in rodents, and the expression of these genes is temporally and tissue specifically regulated. Furthermore, expression of mdr1b is highly elevated during rat hepatocarcinogenesis. To elucidate how mdr1b expression is regulated, we cloned the genomic sequence of the rat mdr1b gene and functionally dissected its 5' promoter region in various cell lines. The transcription start site identified by the primer extension and RNase protection assays is identical to that of the murine mdr1b homologue. Sequence analysis revealed that the proximal region (within -1300 bp) of the rat mdr1b gene also shares striking similarity to that of the mouse mdr1b gene. Transient transfection assays using reporter gene constructs containing various lengths of the 5' mdr1b sequences revealed that the sequence located between-247 to -126 bp was important for the expression of the reporter gene in many different cell lines. Further analyses revealed that at least one regulatory element located at -189 to -167 bp, which contained the palindromic sequence 5'-AGACATGTCT-3' (-189 to -180 bp), is involved in the promoter function. Gel mobility shift assays demonstrated that this palindromic sequence is essential for specific protein binding. UV cross-linking experiments identified that two major proteins with molecular masses of approximately 41 and 49 kDa were associated with this sequence. A Genbank search and gel motility shift assay competition experiment suggested that the specific binding protein(s) appears to be a novel transcription factor involved in the regulation of the rat mdr1b gene expression.

This article has been cited by other articles:

				S. Epsztejn, H. Glickstein, V. Picard, I. N. Slotki, W. Breuer, C. Beaumont, and Z. I. Cabantchik H-Ferritin Subunit Overexpression in Erythroid Cells Reduces the Oxidative Stress Response and Induces Multidrug Resistance Properties Blood, November 15, 1999; 94(10): 3593 - 3603. [Abstract] [Full Text] [PDF]

				G. Zhou and M. T. Kuo Wild-type p53-mediated Induction of Rat mdr1b Expression by the Anticancer Drug Daunorubicin J. Biol. Chem., June 19, 1998; 273(25): 15387 - 15394. [Abstract] [Full Text] [PDF]

				G. Zhou and M. T. Kuo NF-kappa B-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells J. Biol. Chem., June 13, 1997; 272(24): 15174 - 15183. [Abstract] [Full Text] [PDF]

				L. Deng, Y.-C. Lin-Lee, F.-X. Claret, and M. T. Kuo 2-Acetylaminofluorene Up-regulates Rat mdr1b Expression through Generating Reactive Oxygen Species That Activate NF-kappa B Pathway J. Biol. Chem., January 5, 2001; 276(1): 413 - 420. [Abstract] [Full Text] [PDF]